Chapter 23: Infectious Diseases II Flashcards
Perioperative Abx Selection
- Cefazolin (is preferred to prevent MSSA and streptococci infections)
- Clindamycin is alt if beta-lactam allergy
- Vanco if MRSA colonization risk is present
Perioperative Abx Selection: cardiac or vascular surgeries
- Cefazolin or cefuroxime
- Vanco or clinda if beta-lactam allergy
Perioperative Abx Selection: hip fracture repairs / total joint replacments
- Cefazolin
- Vanco or clinda if beta-lactam allergy
Perioperative Abx Selection: Colon (colorectal) or other surgeries involving the abdominal space
Cefotetan, cefoxitin, amp/sulbactam, ertapenem
or
Metronidazole + (cefazolin or ceftriaxone)
Perioperative Abx Selection: Colon (colorectal) or other surgeries involving the abdominal space
Beta-lactam allergy
Clinda + (aminoglycosides, quinolones, or aztreonam)
or
Metronidazole + (aminoglycoside or quinolones)
Meningitis empiric tx: neonate (<1month)
Ampicillin (for listeria coverage) \+ Cefotaxime (NO ceftriaxone) or Gentamicin
Meningitis empiric tx: age 1 month to 50 years
Ceftriaxone or cefotaxime
+
Vanco
Meningitis empiric tx: >50 years or immunocompromised
Ampicillin (for listeria coverage) \+ ceftriaxone or cefotaxime \+ vanco
Acute Otitis Media (AOM) Abx therapy first-line
Amox 80-90mg/kg/day in 2 divided doses
or
Amox/clav 90mg/kg/day (6.4mg/kg/day clav) in 2 divided doses
or
Ceftriaxone 50mg/kg IM or IV for 1 or 3 days (if vomiting and unable to tolerate po)
Acute Otitis Media (AOM) Abx alternative therapy (beta-lactam allergy)
Cefdinir 14mg/kg/day in 1 or 2 doses
Cefuroxime 30mg/kg/day in 2 divided doses
Cefpodoxime 10mg/kg/day in 2 divided doses
Ceftriaxone 50mg/kg IM/IV qd for 1 or 3 days
Common Cold etiology, symptoms, criteria for anti-infective, and tx options
Etiology: respiratory viruses (rhinovirus, seasonal coronavirus)
Symptoms: sneezing, runny nose, cough
Anti-infective: none
Tx: OTC cold medications
Influenza etiology, symptoms, criteria for anti-infective, and tx options
Etiology: influenza virus
Symptoms: sudden onset fever, chills, fatigue, body aches
Criteria for anti-infective: <48 hours since symptom onset
Tx: oseltamivir x 5 days, baloxavir marboxil x 1 dose, zanamivir inh x 5 days
Pharyngitis etiology, symptoms, criteria for anti-infective, and tx options
Etiology: respiratory viruses, S. pyogenes
Symptoms: “strep throat,” sore throat, swollen lymph nodes, white patches on tonsils
Criteria for anti-infective: + rapid antigen diagnostic test
Tx: penicillin or amox or 1st or 2nd gen cephalosporin
Sinusitis etiology, symptoms, criteria for anti-infective, and tx options
S. pneumoniae, H. influenzae, and M. catarrhalis; Staphylococci, anaerobes, gram-neg rods
Symptoms: nasal congestion, purulent nasal discharge, facial/ear/dental pain, headache
Criteria for tx: >=10 days w/symptoms; >=3 days of severe symptoms
Tx: amox/clav
Bronchitis
Causes can include bordetella pertussis (whooping cough), S. pneumoniae, Mycoplasma pneumoniae, H. influenzae
Abx only indicated if whooping cough then treat with azith, clarith, or SMX/TMP
Acute Bacterial Exacerbation of Chronic Bronchitis
ABECB Supportive measures (O2, short-acting bronchodilators, IV or PO steroids) Then abx for 5-7 days if one of the following are met: increased dyspnea, increased sputum volume, increased sputum purulence; mechanically ventilated Preferred abx: amox/clav, azith, doxy
CAP symptoms and diagnostics
- Fever
- Cough with purulent sputum
- Rales (crackling noises in lungs)
- Tachypnea (increased resp rate)
Chest x-ray is gold standard for diagnostics and will have inflitrates, opacities, or consolidation
CAP pathogens
S. pneumoniae, H. influenzae, M. pneumoniae and possibly C. pneumoniae
Outpatient CAP Tx: Category 1
(no comorbidities) Amox high dose (1gm tid) or Doxy or Macrolide (azith or clarith) if local pneumococcal resistance is <25%
Outpatient CAP Tx: Category 2
Comorbidities present (chronic heart, liver, lung, or renal disease; diabetes, alcoholism, malignancy or asplenia)
- Beta-lactam + macrolide or doxy
e. g amox/clav or cephalosporin + macrolide or doxy - Respiratory quinolone monotherapy (levoflox, gemiflox, mociflox)
Inpatient CAP Tx: Non-severe (non-icu)
-Beta-lactam + macrolide or doxy
(preferred beta-lactams: ceftriaxone, cefotaxime, ceftaroline, or amp/sulb)
-Respiratory quinolone monotherapy
Inpatient CAP Tx: Severe (ICU typically required)
- Beta-lactam + macrolide
- Beta-lactam + respiratory quinolone (do not use quinolone monotherapy)
Inpatient CAP Tx: if risk factors for Pseudomonas and/or MRSA add on
MRSA: add coverage with vanco or linezolid
Pseudomonas: add coverage with pip/tazo, cefepime, ceftazidime, imipenem/cilastatin, meropenem or aztreonam
HAP and VAP onset
> 48 hours after hospital admission
>48 hours after start of mechanical ventilation
Common Pathogens in HAP and VAP
- MRSA
- MDR gram-negative rods: P. aeruginosa, Acinetobacter spp. Enterobacter spp. E. coli, and Klebsiella spp.
HAP/VAP Empiric Regimen: Identifying Risk for MRSA and MDR
- Positive MRSA nasal swan
- High prevalence (>10%) of pathogen resistance to any single agent noted in hospital unit
- IV abx within the last 90 days
HAP/VAP Empiric Regimen: all patients need
Coverage for Pseudomonas and MSSA
E.g cefepime and pip/tazo
HAP/VAP Empiric Regimen: MRSA
- Vanco
- Linezolid
For example:
cefepime + vanco
Meropenem + linezolid
HAP/VAP Empiric Regimen: Pseudomonas if risk for MDR pathogens
If patient has risk for MDR pathogens then typically has risk for MRSA. Requires 3 drug regimen)
E.G pip/tazo + cipro + vanco
cefepime + linezolid + gentamicin